Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Taiko Pharmaceutical Co., Ltd. (JP:4574)

:4574

4574

Taiko Pharmaceutical Co., Ltd.

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Taiko Pharmaceutical Co., Ltd. (4574) Ratios

Compare

0 Followers

Taiko Pharmaceutical Co., Ltd. Ratios

JP:4574's free cash flow for Q4 2024 was ¥0.56. For the 2024 fiscal year, JP:4574's free cash flow was decreased by ¥ and operating cash flow was ¥-0.06. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 22	Dec 21	Dec 20
Liquidity Ratios
Current Ratio	4.45	2.71	3.19	2.65	3.46
Quick Ratio	3.90	2.01	2.45	1.79	3.04
Cash Ratio	2.56	1.11	1.34	0.66	2.07
Solvency Ratio	0.46	-0.79	-1.05	0.46	0.48
Operating Cash Flow Ratio	0.62	-0.71	-0.37	-0.20	0.73
Short-Term Operating Cash Flow Coverage	107.86	-1.87	-1.66	-48.81	135.64
Net Current Asset Value	¥ 8.46B	¥ 553.00M	¥ 4.05B	¥ 10.85B	¥ 10.48B
Leverage Ratios
Debt-to-Assets Ratio	<0.01	0.25	0.21	<0.01	<0.01
Debt-to-Equity Ratio	<0.01	0.47	0.37	<0.01	<0.01
Debt-to-Capital Ratio	<0.01	0.32	0.27	<0.01	<0.01
Long-Term Debt-to-Capital Ratio	<0.01	0.25	0.23	<0.01	<0.01
Financial Leverage Ratio	1.24	1.87	1.76	1.39	1.31
Debt Service Coverage Ratio	112.25	-3.50	-6.50	140.33	115.31
Interest Coverage Ratio	0.00	-307.90	-824.67	20.04K	9.71K
Debt to Market Cap	<0.01	0.22	0.13	<0.01	<0.01
Interest Debt Per Share	1.29	87.59	109.84	2.20	1.84
Net Debt to EBITDA	-3.00	-0.19	0.18	-0.82	-2.42
Profitability Margins
Gross Profit Margin	69.01%	21.41%	25.62%	70.24%	70.82%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	23.03%	-74.40%	-51.94%	33.50%	27.22%
Operating Profit Margin	19.56%	-61.09%	-46.16%	31.96%	25.61%
Pretax Profit Margin	19.14%	-96.61%	-82.90%	30.39%	23.46%
Net Profit Margin	13.64%	-97.10%	-89.49%	21.78%	16.43%
Continuous Operations Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Per EBT	71.27%	100.51%	107.94%	71.67%	70.01%
EBT Per EBIT	97.84%	158.14%	179.61%	95.10%	91.63%
Return on Assets (ROA)	6.55%	-32.53%	-42.57%	12.13%	9.63%
Return on Equity (ROE)	8.10%	-60.85%	-74.92%	16.91%	12.66%
Return on Capital Employed (ROCE)	10.81%	-25.13%	-27.16%	23.28%	18.49%
Return on Invested Capital (ROIC)	7.70%	-23.24%	-27.86%	16.67%	12.93%
Return on Tangible Assets	6.63%	-33.01%	-43.14%	12.25%	9.72%
Earnings Yield	5.28%	-28.49%	-26.76%	5.53%	3.70%
Efficiency Ratios
Receivables Turnover	2.85	2.80	2.64	2.23	3.38
Payables Turnover	6.26	14.46	25.80	1.80	4.33
Inventory Turnover	2.09	2.03	2.49	0.82	2.15
Fixed Asset Turnover	1.41	0.79	1.51	1.87	2.10
Asset Turnover	0.48	0.33	0.48	0.56	0.59
Working Capital Turnover Ratio	1.11	0.71	0.98	1.47	1.39
Cash Conversion Cycle	244.72	284.84	270.68	404.79	193.37
Days of Sales Outstanding	128.22	130.21	138.10	163.45	108.00
Days of Inventory Outstanding	174.84	179.87	146.72	444.43	169.62
Days of Payables Outstanding	58.34	25.25	14.15	203.09	84.25
Operating Cycle	303.06	310.09	284.82	607.88	277.61
Cash Flow Ratios
Operating Cash Flow Per Share	40.75	-45.73	-36.66	-35.12	81.97
Free Cash Flow Per Share	28.97	-47.66	-73.43	-86.65	76.80
CapEx Per Share	11.79	1.93	36.77	51.53	5.17
Free Cash Flow to Operating Cash Flow	0.71	1.04	2.00	2.47	0.94
Dividend Paid and CapEx Coverage Ratio	1.74	-23.74	-0.67	-0.49	4.86
Capital Expenditure Coverage Ratio	3.46	-23.74	-1.00	-0.68	15.86
Operating Cash Flow Coverage Ratio	31.55	-0.52	-0.33	-15.99	44.79
Operating Cash Flow to Sales Ratio	0.17	-0.40	-0.15	-0.09	0.23
Free Cash Flow Yield	4.64%	-12.10%	-8.91%	-5.38%	4.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	18.93	-3.51	-3.74	18.08	27.03
Price-to-Sales (P/S) Ratio	2.58	3.41	3.34	3.94	4.44
Price-to-Book (P/B) Ratio	1.53	2.14	2.80	3.06	3.42
Price-to-Free Cash Flow (P/FCF) Ratio	21.56	-8.27	-11.22	-18.60	20.26
Price-to-Operating Cash Flow Ratio	15.33	-8.62	-22.48	-45.90	18.98
Price-to-Earnings Growth (PEG) Ratio	0.68	0.07	0.01	0.33	0.36
Price-to-Fair Value	1.53	2.14	2.80	3.06	3.42
Enterprise Value Multiple	8.21	-4.77	-6.26	10.93	13.89
Enterprise Value	19.63B	17.88B	34.83B	64.77B	56.49B
EV to EBITDA	8.21	-4.77	-6.26	10.93	13.89
EV to Sales	1.89	3.55	3.25	3.66	3.78
EV to Free Cash Flow	15.79	-8.61	-10.90	-17.31	17.26
EV to Operating Cash Flow	11.23	-8.97	-21.84	-42.70	16.17
Tangible Book Value Per Share	402.09	184.46	294.31	527.48	454.58
Shareholders’ Equity Per Share	407.63	184.46	294.31	527.48	454.58
Tax and Other Ratios
Effective Tax Rate	0.29	>-0.01	-0.08	0.28	0.30
Revenue Per Share	241.93	115.59	246.39	409.46	350.46
Net Income Per Share	33.00	-112.24	-220.48	89.18	57.57
Tax Burden	0.71	1.01	1.08	0.72	0.70
Interest Burden	0.90	-	-	-	-
Research & Development to Revenue	0.04	0.00	0.00	0.00	0.00
SG&A to Revenue	0.31	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.88	0.41	0.18	-0.28	1.00

Currency in JPY

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing